James H. Zothantluanga

Mr. James H. Zothantluanga


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2022 in Heliyon
Verified
Journal Article
Open access
SSSriwidodo Sriwidodo
Sriwidodo Sriwidodo
Abd. Kakhar UmarAbd. Kakhar Umar
Abd. Kakhar Umar
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
JZJames H. Zothantluanga
James H. Zothantluanga
SDSanjoy Das
Sanjoy Das
JLJittima Amie Luckanagul
Jittima Amie Luckanagul
Liposomes have been used extensively as micro- and nanocarriers for hydrophobic or hydrophilic molecules. However, conventional liposomes are biodegradable and quickly eliminated, making it difficult to be used for delivery in specific routes, such as the oral and systemic routes. One way to overcome this problem is through complexation with polymers, which is referred to as a liposome complex. The use of polymers can increase the stability of liposome with regard to pH, chemicals, enzymes, and the immune system. In some cases, specific polymers can condition the properties of liposomes to be explicitly used in drug delivery, such as targeted delivery and controlled release. These properties are influenced by the type of polymer, crosslinker, interaction, and bond in the complexation process. Therefore, it is crucial to study and review these parameters for the development of more optimal forms and properties of the liposome complex. This article discusses the use of natural and synthetic polymers, ways of interaction between polymers and liposomes (on the surface, incorporation in lamellar chains, and within liposomes), types of bonds, evaluation standards, and their effects on the stability and pharmacokinetic profile of the liposome complex, drugs, and vaccines. This article concludes that both natural and synthetic polymers can be used in modifying the structure and physicochemical properties of liposomes to specify their use in targeted delivery, controlled release, and stabilizing drugs and vaccines.

8 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Mithun RudrapalMithun Rudrapal
Mithun Rudrapal
AMAshwini Kumar Mishra
Ashwini Kumar Mishra
LRLaxmi Rani
Laxmi Rani
KSKhomendra K. Sarwa
Khomendra K. Sarwa
JZJames H. Zothantluanga
James H. Zothantluanga
PSPravat K. Sahoo
Pravat K. Sahoo
Advancement in nanotechnology has unleashed the therapeutic potentials of dietary polyphenols by enhancing bioavailability, improving biological half-life, and allowing site-specific drug delivery. In this review, through citation of relevant literature reports, we discuss the application of nano-pharmaceutical formulations, such as solid lipid nanoparticles, nano-emulsions, nano-crystals, nano-polymersomes, liposomes, ethosomes, phytosomes, and invasomes for dietary polyphenols. Following this, we highlight important studies concerning different combinations of nano formulations with dietary polyphenols (also known as nanophytopolyphenols). We also provide nano-formulation paradigms for enhancing the physicochemical properties of dietary polyphenols. Finally, we highlight the latest patents that were granted on nano-formulations of dietary polyphenols. Based on our review, we observe that nanosized delivery of herbal constituents, spices, and dietary supplements have the ability to improve biological processes and address issues connected with herbal treatments.


8 October 2021 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
PPPraveen Kumar Pasala
Praveen Kumar Pasala
RSRizwaan Abbas Shaik
Rizwaan Abbas Shaik
Mithun RudrapalMithun Rudrapal
Mithun Rudrapal
JKJOHRA KHAN
JOHRA KHAN
Mohammed AlaidarousMohammed Alaidarous
Mohammed Alaidarous
SWSanjay G. Walode
Sanjay G. Walode
This study involved cerebroprotective potential of aloe emodin (AE) by in silico molecular docking analysis against various cerebrotoxic proteins followed by in vivo activity on multiple occlusions and reperfusion of bilateral carotid arteries (MO/RCA) induced cerebral injury in experimental rats. Molecular docking studies were carried out to evaluate the binding affinity (or binding interaction) between AE and various proteins involved in apoptosis such as caspase-3 (CASP3) and Bcl-2-associated X protein (BAX), and proteins involved in inflammation such as interleukin-6 (IL-6), tumor necrosis factor α (TNF α), nitric oxide synthase (NOS), acid-sensing ion channel (ASIC) and glutamate receptor (GR) involved in cerebral stroke, and results were compared with that of standard drugs, minocycline, quercetin, and memantine. Cerebral ischemic reperfusion induced by MO/RCA was assessed for 10 mins reperfusion period as one cycle, and the experiment was conducted for up to 3 cycles in rats. After completion of 3 cycles, the rats were subjected to ethically acceptable animal euthanasia followed by isolation of the brains which were studied for the size of cerebral infarction, and biochemical parameters such as glutathione (GSH), malondialdehyde (MDA), catalase (CAT) were estimated from the brain homogenate. Further, histological studies were done to study neuronal contact. Results of molecular docking indicated that the AE exhibited interaction with active sites of cerebrotoxic proteins usually involved in protein functions or cerebrotoxicity. Biochemical results showed that in the untreated brain, MDA levels increased significantly, and decreased GSH and CAT levels were observed when compared to MO/RCA group, while treated rats showed a decrease in the levels of MDA and an increase in GSH and CAT levels as compared to MO/RCA rats. In comparison with sham rats and normal rats, histopathological analysis revealed neuronal damage in MO/RCA surgery rats which manifested as decreased intact neurons. However, treatment with AE 50 mg/kg b.wt. restored contact between neuronal cells. It can be concluded that AE showed cerebroprotective effect on RO/RCA with promising inhibition of cerebrotoxic proteins (apoptotic and neuroinflammatory) as evident from molecular docking studies. The cerebroprotective potential of AE could be due to its anti-inflammatory, antioxidant, and antiapoptotic principles.

19 April 2022 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PPPraveen Kumar Pasala
Praveen Kumar Pasala
RURamya K. Uppara
Ramya K. Uppara
Mithun RudrapalMithun Rudrapal
Mithun Rudrapal
JZJames H. Zothantluanga
James H. Zothantluanga
Abd. Kakhar UmarAbd. Kakhar Umar
Abd. Kakhar Umar

30 June 2020 in Science Vision
Verified
Journal Article
Open access
SPSujata Paul
Sujata Paul
EHEl Bethel Lalthavel Hmar
El Bethel Lalthavel Hmar
JZJames H. Zothantluanga
James H. Zothantluanga
HSHemanta Kumar Sharma
Hemanta Kumar Sharma
Essential oils are volatile, complex products of plants as secondary metabolites and include terpenes and their oxygenated derivatives, such as alcohols, aldehydes, esters, ketones, phenols and oxides. In recent years, out of 3000 essential oils obtained from plant origin only 300 essential oils have gained extensive attention for applications in various fields. In this review, we discuss the major biological activities associated with EOs as antimicrobial, antispasmodic, antioxidant, antiviral, anti-inflammatory, anthelmintic, insecticidal, antiparasitic, and cytotoxic agents. Different routes for delivery of essential oil along with the problems associated with essential oils like high volatility, low stability, permeability, bioavailability, poor water solubility, susceptibility to oxidation, decomposition, photosensitization and skin irritation are also highlighted. Furthermore, strategies to solve the mentioned problems are suggested by different nanoencapsulating systems. These include polymer-based nanocarriers, lipid-based nanocarriers and molecular complexes. It is believed that nanoencapsulation of essential oils will improve their therapeutic activity and delivery.